BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17021)

  • 1. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1977 May; 30(5):315-20. PubMed ID: 17021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
    Andreoni O
    Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of in vitro antibacterial potencies of oral antibiotics against sputum isolates].
    Yamada H; Nakanishi H; Yamaguchi M; Nagasawa Z
    Jpn J Antibiot; 1983 Aug; 36(8):2103-8. PubMed ID: 6361322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity of bacteria inducing urinary infections to 3 drugs (amoxicillin, ampicillin and cephalexin) and clinical efficacy of amoxicillin (author's transl)].
    Fukushima S; Fujii H; Kitajima N; Suzuki M
    Jpn J Antibiot; 1975 Dec; 28(6):795-801. PubMed ID: 1104914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
    Igari J; Oguri T; Tachibana Y; Misawa N; Nakamura A; Shitara M; Umezu S; Nakamura Y; Tazawa S; Shimoura M; Ugajin K; Mori T; Shimada J; Kaku M; Murase M; Hirakata Y; Matsuda J
    Jpn J Antibiot; 1997 Jul; 50(7):640-9. PubMed ID: 9743909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents.
    Nishijima S; Namura S; Kawai S; Akamatsu H; Asada Y; Kawabata S
    J Dermatol; 1994 Apr; 21(4):233-8. PubMed ID: 8056894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Annual changes in susceptibility of clinical isolates to midecamycin acetate].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Aug; 43(8):1341-52. PubMed ID: 2283704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
    Yamaguchi K; Ohno A; Takahashi S; Hayashi M; Yamanaka K; Hirakata Y; Mitsuyama J
    Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Actual resistance of Staphylococcus aureus: beta-Lactamase production and susceptibility to various penicillins and erythromycin (author's transl)].
    Haller I; Heinrich S
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Apr; 251(4):479-86. PubMed ID: 6980543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
    Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. II].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1587-602. PubMed ID: 3900459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
    Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility studies with josamycin and erythromycin.
    Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
    Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
    Minguez F; Ramos C; Loscos A; Chiu ML; Prieto J
    Chemotherapy; 1993; 39(3):163-8. PubMed ID: 8389685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.